Claim/exemption information - Registry number 11845

Case number
2020-011981
Claimant name
Halliburton Group Canada
Product identifier
SSO-21M WINTERIZED
Claim type
Original
Date of filing
Non-compliance(s) identified on SDS and/or label
Yes, Order issued
SDS and/or label compliance review decision date
Claim/exemption status
Withdrawn
Date of claim/exemption status

Additional information

Date of the order
Order status
Unresolved

List of suggested corrective measures

  • Correct administrative non-compliances.

  • Correct the disclosure of misleading information regarding fire-fighting measures.

  • Correct the disclosure of misleading information regarding first aid measures.

  • Correct the disclosure of misleading information regarding the LD50 values for the ingredients “ethylene glycol monobutyl ether”, “poly(oxy-1,2-ethandiyl), a-(nonylphenyl)-w-hydroxy-” and “alkylalcohol”.

  • Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

  • Disclose information on the precautions for firefighters.

  • Disclose the additional hazard classifications of “Acute Toxicity (Dermal) — Category 4”, “Acute Toxicity (Inhalation) — Category 3”, “Skin Corrosion — Category 1” and “Specific Target Organ Toxicity — Single Exposure — Category 3, narcotic effects (central nervous system)”.

  • Disclose the applicable common names and synonyms for the ingredients “ethylene glycol monobutyl ether” and “methanol”.

  • Disclose the calculated product oral ATE value of 629 mg/kg (9% unknown), the calculated product dermal ATE value of 1 449 mg/kg (9% unknown), the calculated product inhalation (vapour) ATE value of 5.1 mg/L (54% unknown) and the calculated product inhalation (dust/mist) ATE value of 6.1 mg/L (80% unknown).

  • Disclose the hazardous combustion products.

  • Disclose the information elements concerning the additional hazard and precautionary statements.

  • Disclose the percent of unknown toxicity of “9%” for the calculated product oral and dermal ATE values, respectively, “54%” for the inhalation (vapours) ATE value and “80%” for the inhalation (dust/must) ATE value.

  • Disclose the symbol and/or name of the symbol for “Skull and crossbones” on the SDS.

  • Disclose “ingestion” as an additional likely route of exposure.

  • Disclose “static discharge” as a condition to avoid.

  • Disclose “strong acids” as an incompatible material.